Update of PDE5 inhibitors for the treatment of ischemia-reperfusion / 中华男科学杂志
National Journal of Andrology
;
(12): 842-846, 2011.
Artículo
en Chino
| WPRIM
| ID: wpr-305776
ABSTRACT
Phosphodiesterase type 5 (PDE5) inhibitors are used most commonly in the treatment of penile erectile dysfunction (ED). Recent studies show that PDE5 inhibitors are ideal drugs for treating ischemia-reperfusion injury. This review focuses on the results of basic and clinical researches on PDE5 inhibitors for the treatment of ischemia-reperfusion injury and provides some theoretical evidence for clinical options of the drugs.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Inhibidores de Fosfodiesterasa
/
Daño por Reperfusión
/
Usos Terapéuticos
/
Quimioterapia
/
Inhibidores de Fosfodiesterasa 5
/
Disfunción Eréctil
Límite:
Humanos
/
Masculino
Idioma:
Chino
Revista:
National Journal of Andrology
Año:
2011
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS